{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:36:31Z","timestamp":1792546591803,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2,1]]},"DOI":"10.1093\/jac\/dkh524","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T20:18:54Z","timestamp":1105647534000},"page":"178-181","source":"Crossref","is-referenced-by-count":79,"title":["Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium"],"prefix":"10.1093","volume":"55","author":[{"given":"A.","family":"Boulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Rolain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Raoult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,2]]},"reference":[{"key":"key\n\t\t\t\t20171013013814_R1","doi-asserted-by":"crossref","unstructured":"Raoult, D., Birg, M. L., La Scola, B. et al. (2000). Cultivation of the bacillus of Whipple's disease. New England Journal of Medicine342, 620\u20135.","DOI":"10.1056\/NEJM200003023420903"},{"key":"key\n\t\t\t\t20171013013814_R2","doi-asserted-by":"crossref","unstructured":"Fenollar, F. & Raoult, D. (2001). Whipple's disease. Clinical and Diagnostic Laboratory Immunology8, 1\u20138.","DOI":"10.1128\/CDLI.8.1.1-8.2001"},{"key":"key\n\t\t\t\t20171013013814_R3","doi-asserted-by":"crossref","unstructured":"Singer, R. (1998). Diagnosis and treatment of Whipple's disease. Drugs55, 699\u2013704.","DOI":"10.2165\/00003495-199855050-00007"},{"key":"key\n\t\t\t\t20171013013814_R4","doi-asserted-by":"crossref","unstructured":"Fleming, J. L., Wiesner, R. H. & Shorter, R. G. (1988). Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clinic Proceedings63, 539\u201351.","DOI":"10.1016\/S0025-6196(12)64884-8"},{"key":"key\n\t\t\t\t20171013013814_R5","unstructured":"Maizel, H., Ruffin, J. & Dobbins, W. (1970). Whipple's disease: a review of 19 patients from one hospital and a review of the literature since 1950. Medicine49, 175\u2013205."},{"key":"key\n\t\t\t\t20171013013814_R6","doi-asserted-by":"crossref","unstructured":"Dykman, D. D., Cuccherini, B. A., Fuss, J. J. et al. (1999). Whipple's disease in a father\u2013daughter pair. Digestive Disease Science44, 2542\u20134.","DOI":"10.1023\/A:1026607726745"},{"key":"key\n\t\t\t\t20171013013814_R7","doi-asserted-by":"crossref","unstructured":"Boulos, A., Rolain, J. M. & Raoult, D. (2004). Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrobial Agents and Chemotherapy48, 747\u201352.","DOI":"10.1128\/AAC.48.3.747-752.2004"},{"key":"key\n\t\t\t\t20171013013814_R8","doi-asserted-by":"crossref","unstructured":"La Scola, B., Fenollar, F., Fournier, P. E. et al. (2001). Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus. International Journal of Systematic Evolutionary Microbiology51, 1471\u20139.","DOI":"10.1099\/00207713-51-4-1471"},{"key":"key\n\t\t\t\t20171013013814_R9","doi-asserted-by":"crossref","unstructured":"Bentley, S. D., Maiwald, M., Murphy, L. D. et al. (2003). Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei. Lancet361, 637\u201344.","DOI":"10.1016\/S0140-6736(03)12597-4"},{"key":"key\n\t\t\t\t20171013013814_R10","doi-asserted-by":"crossref","unstructured":"Fenollar, F., Birg, M. L., Gauduchon, V. et al. (2003). Culture of Tropheryma whipplei from human samples: a 3-year experience (1999 to 2002). Journal of Clinical Microbiology41, 3816\u201322.","DOI":"10.1128\/JCM.41.8.3816-3822.2003"},{"key":"key\n\t\t\t\t20171013013814_R11","doi-asserted-by":"crossref","unstructured":"Raoult, D., La Scola, B., Lecocq, P. et al. (2001). Culture and immunological detection of Tropheryma whippelii from the duodenum of a patient with Whipple disease. Journal of the American Medical Association285, 1039\u201343.","DOI":"10.1001\/jama.285.8.1039"},{"key":"key\n\t\t\t\t20171013013814_R12","doi-asserted-by":"crossref","unstructured":"Raoult, D., Ogata, H., Audic, S. et al. (2003). Tropheryma whipplei Twist: a human pathogenic actinobacteria with a reduced genome. Genome Research13, 1800\u20139.","DOI":"10.1101\/gr.1474603"},{"key":"key\n\t\t\t\t20171013013814_R13","doi-asserted-by":"crossref","unstructured":"Renesto, P., Crapoulet, N., Ogata, H. et al. (2003). Genome-based design of a cell-free culture medium for Tropheryma whipplei. Lancet362, 447\u20139.","DOI":"10.1016\/S0140-6736(03)14071-8"},{"key":"key\n\t\t\t\t20171013013814_R14","doi-asserted-by":"crossref","unstructured":"Masselot, F., Boulos, A., Maurin, M. et al. (2003). Molecular evaluation of antibiotic susceptibility, the Tropheryma whipplei paradigm. Antimicrobial Agents and Chemotherapy47, 1658\u201364.","DOI":"10.1128\/AAC.47.5.1658-1664.2003"},{"key":"key\n\t\t\t\t20171013013814_R15","doi-asserted-by":"crossref","unstructured":"Rolain, J. M., Maurin, M. & Raoult, D. (2000). Bactericidal effect of antibiotics on Bartonella and Brucella spp.: clinical implications. Journal of Antimicrobial Chemotherapy46, 811\u20134.","DOI":"10.1093\/jac\/46.5.811"},{"key":"key\n\t\t\t\t20171013013814_R16","doi-asserted-by":"crossref","unstructured":"Ghigo, E., Capo, C., Aurouze, M. et al. (2002). Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification. Infection and Immunity70, 1501\u20136.","DOI":"10.1128\/IAI.70.3.1501-1506.2002"},{"key":"key\n\t\t\t\t20171013013814_R17","unstructured":"Rittenbury, M. S. (1990). How and why aztreonam works. Surgery Gynecology & Obstetrics171, Suppl., 19\u201323."},{"key":"key\n\t\t\t\t20171013013814_R18","doi-asserted-by":"crossref","unstructured":"Cannon, R. (2003). Whipple's disease, genomics, and drug therapy. Lancet361, 1916.","DOI":"10.1016\/S0140-6736(03)13533-7"},{"key":"key\n\t\t\t\t20171013013814_R19","doi-asserted-by":"crossref","unstructured":"Gibreel, A. & Skold, O. (1998). High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases. Antimicrobial Agents and Chemotherapy42, 3059\u201364.","DOI":"10.1128\/AAC.42.12.3059"},{"key":"key\n\t\t\t\t20171013013814_R20","doi-asserted-by":"crossref","unstructured":"Levy, M., Poyart, C., Lamarque, D. et al. (2000). Whipple's disease: acquired resistance to trimethoprim-sulfamethoxazole. American Journal of Gastroenterology95, 2390\u20131.","DOI":"10.1111\/j.1572-0241.2000.02345.x"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/2\/178\/2544490\/dkh524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T11:26:41Z","timestamp":1682940401000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/2\/178\/856775\/Molecular-evaluation-of-antibiotic-susceptibility"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,2]]},"published-print":{"date-parts":[[2005,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh524","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,2]]},"published":{"date-parts":[[2005,2,1]]}}}